Other

Less than 12 months

Edwards Lifesciences Less than 12 months increased by 432.2% to $435.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5341.3%, from $8.00M to $435.30M. Over 4 years (FY 2021 to FY 2025), Less than 12 months shows a downward trend with a -52.7% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2017
Last reportedQ1 2026May 6, 2026
Metric ID: other_debt_securities_available_for_sale_continuous_unre_4cdf47

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$382.00M$582.70M$1.63B$1.61B$1.54B$1.24B$353.90M$100.50M$85.10M$21.40M$35.20M$12.20M$5.10M$3.60M$8.40M$8.00M$8.70M$11.30M$81.80M$435.30M
QoQ Change+52.5%+180.2%-1.3%-4.3%-19.4%-71.5%-71.6%-15.3%-74.9%+64.5%-65.3%-58.2%-29.4%+133.3%-4.8%+8.8%+29.9%+623.9%+432.2%
YoY Change+303.5%+113.1%-78.3%-93.8%-94.5%-98.3%-90.1%-87.9%-94.0%-83.2%-76.1%-34.4%+70.6%+213.9%+873.8%>999%
Range$3.60M$1.63B
CAGR+2.8%
Avg YoY Growth+380.4%
Median YoY Growth-77.2%
Current Streak4 quarters growth

Less than 12 months at Other Companies

Frequently Asked Questions

What is Edwards Lifesciences's less than 12 months?
Edwards Lifesciences (EW) reported less than 12 months of $435.30M in Q1 2026.
How has Edwards Lifesciences's less than 12 months changed year-over-year?
Edwards Lifesciences's less than 12 months increased by 5341.3% year-over-year, from $8.00M to $435.30M.
What is the long-term trend for Edwards Lifesciences's less than 12 months?
Over 4 years (2021 to 2025), Edwards Lifesciences's less than 12 months has grown at a -52.7% compound annual growth rate (CAGR), from $1.63B to $81.80M.